Gables Capital Management’s Novartis NVS Stock Holding History

Gables Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,277	Closed	-$109K	–	365
2021 Q1	$109K	Hold	1,277	–	–	0.06%	160
2020 Q4	$121K	Hold	1,277	–	–	0.07%	147
2020 Q3	$111K	Hold	1,277	–	–	0.07%	145
2020 Q2	$112K	Hold	1,277	–	–	0.08%	141
2020 Q1	$105K	Hold	1,277	–	–	0.09%	139
2019 Q4	$121K	Hold	1,277	–	–	0.08%	148
2019 Q3	$111K	Hold	1,277	–	–	0.08%	151
2019 Q2	$117K	Sell	1,277 -148	-10%	-$12.5K	0.1%	132
2019 Q1	$123K	Hold	1,425	–	–	0.1%	129
2018 Q4	$110K	Hold	1,425	–	–	0.1%	127
2018 Q3	$110K	Hold	1,425	–	–	0.08%	133
2018 Q2	$95K	Hold	1,425	–	–	0.08%	137
2018 Q1	$103K	Buy	+1,425	New	+$108K	0.09%	134

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Gables Capital Management's NVS Position: Q2 2021 in Review

Gables Capital Management sold out of Novartis (NVS) in Q2 2021, closing a stake of 1,277 shares — an estimated $109K sold.

Gables Capital Management first reported a position in NVS in Q1 2018 and held it in 13 quarters. The position peaked at $123K in Q1 2019. 1,119 funds tracked by Wall St. Rank hold NVS as of Q2 2021.

Gables Capital Management reported no remaining Novartis position as of Q2 2021 after selling out during the quarter.
Gables Capital Management sold 1,277 Novartis shares in Q2 2021, an estimated $109K.
Gables Capital Management first reported a position in Novartis in Q1 2018 and held it in 13 quarters.
Gables Capital Management's Novartis position peaked at $123K in Q1 2019.
1,119 funds tracked by Wall St. Rank held Novartis as of Q2 2021.

Based on Gables Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.